Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Type 1 Diabetes Mellitus on Body Composition and Glucose Variabilities: Single-Arm, Exploratory Trial

INTRODUCTION: Sodium glucose co-transporter 2 (SGLT2) inhibitors are widely used in the management of type 2 diabetes mellitus; they prevent cardiovascular events and reduce fat mass. However, little is known about the effects of SGLT2 inhibitors on type 1 diabetes mellitus as an adjuvant to insulin...

Descripción completa

Detalles Bibliográficos
Autores principales: Baba, Yusuke, Ishibashi, Ryoichi, Takasaki, Atsushi, Ito, Chiho, Watanabe, Atsuko, Tokita, Megumi, Meguro, Miwako, Harama, Tomomi, Hirayama, Kiichi, Yamamoto, Tetsuya, Nakamura, Susumu, Koshizaka, Masaya, Maezawa, Yoshiro, Uchida, Daigaku, Okajima, Fumitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099976/
https://www.ncbi.nlm.nih.gov/pubmed/33738773
http://dx.doi.org/10.1007/s13300-021-01047-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099976/
https://www.ncbi.nlm.nih.gov/pubmed/33738773
http://dx.doi.org/10.1007/s13300-021-01047-5

Ejemplares similares